StatPearls, LLC

  • Choroidal Neovascularization
  • Endothelial Growth Factors
  • Macular Degeneration
  • Myopia, Degenerative
  • Scotoma

Degenerative Myopia

Pathological myopia is a progressive eye condition characterized by excessive eyeball elongation, leading to biomechanical stretching of the retina, choroid, and sclera. This abnormal growth causes significant changes in ocular structures, increasing the risk of severe complications such as retinal detachment, myopic maculopathy, and choroidal neovascularization. Patients with pathological myopia may present with symptoms like scotomas, metamorphopsia, and floaters. Early detection is crucial to prevent irreversible vision loss, and management often includes optical interventions, anti-vascular endothelial growth factor therapy, or surgical treatments, depending on the severity of complications. This course enhances the participant’s ability to recognize the clinical manifestations of pathological myopia, perform appropriate diagnostic evaluations, and implement timely management strategies. By collaborating with an interprofessional team including ophthalmologists, optometrists, and retinal specialists clinicians ensure comprehensive care that addresses the patient’s medical and lifestyle needs. This coordinated approach improves visual outcomes and enhances the overall quality of life for individuals with pathological myopia, primarily through early intervention and tailored long-term management plans.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left